|
|||||
|
|
A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report |
|
| Authors: | Anne L. Angiolillo MD Alice L. Yu MD PhD Gregory Reaman MD Ashish M. Ingle MS Rita Secola MSN Peter C. Adamson MD |
| Affiliation: | 1. Division of Oncology, Children's National Medical Center, Washington, District of Columbia;2. Department of Pediatrics, Rady Children's Hospital San Diego, San Diego, California;3. Children's Oncology Group‐Chair's Office, Bethesda, Maryland;4. Children's Oncology Group‐Operations Center, Arcadia, California;5. Children's Hospital of Los Angeles, Los Angeles, California;6. Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania |
| Abstract: | |
| Keywords: | acute lymphoblastic leukemia Campath‐1H relapse |